Innate Pharma SA
LSE:0EVI
Innate Pharma SA
LSE:0EVI
Price:
1.544
EUR
-1.59%
Market Closed
Market Cap:
€125m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
LSE:0EVI
|
FR |
|
W
|
WEG SA
F:B7F0
|
BR |
|
A
|
Ad Pepper Media International NV
DUS:APM
|
DE |
|
S
|
Stroeer SE & Co KgaA
XMUN:SAX
|
DE |
Wall St Price Targets
0EVI Price Targets Summary
Innate Pharma SA
Innate Pharma SA
Wall Street analysts forecast 0EVI stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0EVI is 5.444 EUR with a low forecast of 4.534 EUR and a high forecast of 6.494 EUR.
Lowest Forecast
Price Target
4.534
EUR
194% Upside
Average Forecast
Price Target
5.444
EUR
253% Upside
Highest Forecast
Price Target
6.494
EUR
321% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0EVI's stock price target?
Price Target
5.444
EUR
5.444
EUR
According to Wall Street analysts, the average 1-year price target for 0EVI is 5.444 EUR with a low forecast of 4.534 EUR and a high forecast of 6.494 EUR.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
92%
92%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 7 years is 92%.
